The US Food and Drug Administration (FDA) has expanded the indication for Abbott Laboratories spinal cord stimulation (SCS) devices to include treatment of chronic back pain.
A large survey of medical cannabis users with chronic pain and mental health issues shows improvement in health and functioning and reduced opioid use.